These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 591759)

  • 21. Effectiveness of ursodeoxycholic acid in gallstone therapy.
    Kutz K; Schulte A
    Gastroenterology; 1977 Sep; 73(3):632-3. PubMed ID: 892365
    [No Abstract]   [Full Text] [Related]  

  • 22. Gallstones: current concepts of pathogenesis and medical dissolution.
    Shaffer EA
    Can J Surg; 1980 Nov; 23(6):517-32, 557. PubMed ID: 7004612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical treatment of gallstones.
    Summerfield JA
    Br J Hosp Med; 1979 May; 21(5):482-9. PubMed ID: 486832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
    Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
    J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies on the therapeutic significance of ursodeoxycholic acid in the intravital dissolution of biliary calculi using chenodeoxycholic acid].
    Fromm H; Erbler HC; Eschler A; Schmidt FW
    Z Gastroenterol Verh; 1976; (9):37-9. PubMed ID: 64082
    [No Abstract]   [Full Text] [Related]  

  • 26. Proceedings: Is intermittent chenodeoxycholic acid therapy feasible for dissolving gallstones? The speed of change in biliary lipids and bile acids after starting and stopping treatment.
    Iser JH; Murphy GM; Dowling RH
    Gut; 1975 Oct; 16(10):840. PubMed ID: 1205324
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of ursodeoxycholic acid on biliary lipid and bile acids composition in patients with gallstones: a dose-response study (author's transl)].
    Sugata F; Yamanaka M; Matsumoto T; Katsuta N
    Nihon Shokakibyo Gakkai Zasshi; 1978 Apr; 75(4):492-9. PubMed ID: 660983
    [No Abstract]   [Full Text] [Related]  

  • 28. [Chemical treatment of gallbladder and bile duct calculi. Current status and critical comment].
    Leuschner U
    Med Klin (Munich); 1986 Mar; 81(6):217-22. PubMed ID: 3785080
    [No Abstract]   [Full Text] [Related]  

  • 29. Chenotherapy for gallstone dissolution. II. Induced changes in bile composition and gallstone response.
    Hofmann AF; Thistle JL; Klein PD; Szczepanik PA; Yu PY
    JAMA; 1978 Mar; 239(12):1138-44. PubMed ID: 628065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Medical treatment of biliary lithiasis].
    Poupon R
    Chirurgie; 1987; 113(6):514-8. PubMed ID: 3436208
    [No Abstract]   [Full Text] [Related]  

  • 31. Gallstone dissolution in vitro by bile acids, heparin, and quanternary amines.
    Lahana DA; Bonorris GG; Schoenfield LJ
    Surg Gynecol Obstet; 1974 May; 138(5):683-5. PubMed ID: 4823370
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of gallstones with chenodeoxy-and ursodeoxycholic acid; the influence of presence or absence of hyperlipidemia on gallstone dissolution.
    Kajiyama G; Maruhashi A; Mizuno T; Yamada K; Kawamoto T; Fujiyama M; Kubota S; Sasaki H; Oyamada K; Nakao S; Miyoshi A
    Hiroshima J Med Sci; 1979 Jun; 28(2):67-71. PubMed ID: 478985
    [No Abstract]   [Full Text] [Related]  

  • 33. Bile acids in bile during long-term chenodeoxycholic acid treatment.
    Bremmelgaard A; Pedersen L
    Scand J Gastroenterol; 1976; 11(2):161-5. PubMed ID: 1265436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Protein and pigment metabolism in the liver of patients with gallstones before and after treatment with cheno- and ursodeoxycholic acid preparations].
    Grebenev AL; Palinkashin DG; Genia LP; Golochevskaia VS; Lemeshko ZA
    Klin Med (Mosk); 1988 Mar; 66(3):96-9. PubMed ID: 3392933
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of cholesterol gallstones with ursodesoxycholic acid (author's transl)].
    Bernades P; Bertrand L; Bouvry M; Colin R; Geffroy Y; Hecht Y; Klepping C; Lambert R; Levy VG; Michel H; Paliard P; Paris J; Quinton A
    Nouv Presse Med; 1982 Feb; 11(8):587-9. PubMed ID: 7041086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones.
    Coyne MJ; Bonorris GG; Goldstein LI; Schoenfield LJ
    J Lab Clin Med; 1976 Feb; 87(2):281-91. PubMed ID: 1245792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Symposium on pathophysiology of biliary tract diseases with special emphasis on gallstone disease. (4) Pathogenesis of cholesterol gallstone (author's transl)].
    Osuga T; Fujita R
    Nihon Naika Gakkai Zasshi; 1977 Sep; 66(9):1190-5. PubMed ID: 412902
    [No Abstract]   [Full Text] [Related]  

  • 38. Dissolution of gallstones with bile salts, lecithin, and heparin.
    Cheung LY; Englert E; Moody FG; Wales EE
    Surgery; 1974 Sep; 76(3):500-3. PubMed ID: 4851407
    [No Abstract]   [Full Text] [Related]  

  • 39. Mass spectrometry identification of biliary bile acids in bile from patients with gallstones before and during treatment with chenodeoxycholic acid. An ancillary study of the National Cooperative Gallstone Study.
    Stellaard F; Klein PD; Hofmann AF; Lachin JM
    J Lab Clin Med; 1985 Apr; 105(4):504-13. PubMed ID: 3981060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cheno and urso compared and contrasted.
    Dowling RH
    Acta Med Port; 1983 Jan; 4(1):51-62. PubMed ID: 6337454
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.